Expert Interview
Looking at the potential usage of Roche's newly approved 18-minute Elecsys PRO-C3 blood test to assess the severity of liver fibrosis in patients showing signs of metabolic dysfunction–associated steatotic liver disease (MASLD)
Ticker(s): RHHBYInstitution: University of North Carolina
- Gastroenterologish/Hepatologist at UNC Rex Digestive Healthcare
- Manages 5-10 patients with PBC
- Clinical interests in upper GI endoscpoy and Primary Biliary Cholangitis
Describe your background and current practice setting
Added By: ben_adminWhat is your opinion on the potential of the Elecsys PRO-C3 blood test?
What is the current gold standard for the diagnosis of an MASLD?
Added By: ben_adminRank your excitement for the Elecsys PRO-C3 blood test on a scale of 1-10?
Added By: ben_adminHow many patients with MASLD do you manage?
Added By: ben_adminAre You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
